(Q45765914)

English

Active specific immunotherapy of pulmonary metastasis with vaccinia melanoma oncolysate prepared from granulocyte/macrophage-colony-stimulating-factor-gene-encoded vaccinia virus

scientific article published in January 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8954168

Active specific immunotherapy of pulmonary metastasis with vaccinia melanoma oncolysate prepared from granulocyte/macrophage-colony-stimulating-factor-gene-encoded vaccinia virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8954168

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

author name string

D W Ju

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8954168

X Cao

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8954168

B Acres

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8954168

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8954168

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8954168

122

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8954168

12

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8954168

716-722

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8954168

https://scigraph.springernature.com/pub.10.1007/bf01209118

0 references

In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific tumor immunity produced by the injection of vaccinia viral oncolysates

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological response modifiers: the new immunotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccinia virus: a selectable eukaryotic cloning and expression vector

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccinia virus: a tool for research and vaccine development

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo kinetics of recombinant vaccinia virus cancer-gene therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccinia virus-infected C-C36 colon tumor cell lysates stimulate cellular responses in vitro and protect syngeneic Balb/c mice from tumor cell challenge

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active specific immunotherapy with vaccinia colon oncolysate enhances the immunomodulatory and antitumor effects of interleukin-2 and interferon alpha in a murine hepatic metastasis model

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor effect induced by granulocyte/macrophage-colony-stimulating factor gene-modified tumor vaccination: comparison of adenovirus- and retrovirus-mediated genetic transduction

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant vaccinia interleukin-2-infected tumor cell vaccines in immunotherapy of murine colon adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of antitumor immunity and treatment of preestablished tumor by interleukin-6-gene-transfected melanoma cells combined with low-dose interleukin-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo delivery of interleukin-4 by a recombinant vaccinia virus prevents tumor development in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Directed cytokine expression in tumour cells in vivo using recombinant vaccinia virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitory effects of triazolodiazepine on mouse splenocytes and peritoneal macrophages in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma. Treatment of stage II melanoma with viral lysates

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced efficacy of combination of IL-2 gene and IL-6 gene-transfected tumor cells in the treatment of established metastatic tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccinia-interleukin 2 recombinant virus or exogenous interleukin 2 does not alter the magnitude or immune response gene defects of the cytotoxic T-cell response to vaccinia virus in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene therapy for cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of platelet activating factor antagonist WEB 2086 on the production of TNF from murine peritoneal macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/8954168

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01209118

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8954168

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/8954168

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45765914&oldid=2081442278"